North America Respiratory Care Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Product, Indication and End User – QNT Press Release


DUBLIN, Sept. 22, 2022 /PRNewswire/ — The “North America Respiratory Care Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Product, Indication and End User” report has been added to ResearchAndMarkets.com’s offering.

The North America respiratory care devices market is expected to grow from US$ 7,319.58 million in 2022 to US$ 12,139.81 million by 2028; it is estimated to grow at a CAGR of 8.8% from 2022 to 2028.

Infectious respiratory diseases are creating a rising burden on the healthcare system across North America. The diseases can be induced due to several factors associated with immune deficiency. Most infectious respiratory diseases are spread from person to person through mucus and saliva and are caused by microorganisms that can infect the respiratory system. The severity of contagious respiratory diseases ranges from mild to severe. Tuberculosis (TB), COVID-19, influenza, diphtheria, measles, pneumonia, pertussis, and respiratory syncytial virus (RSV) are a few examples of infectious respiratory diseases.

Among the infectious respiratory diseases, TB was on the top of the list for high prevalence before the COVID-19 pandemic. Moreover, according to the Centers for Disease Control and Prevention (CDC) data, TB incidence (cases per 100,000 population) among Americans increased from 0.71 in 2020 to 0.79 in 2021. Among non-Americans, it increased from 11.71 in 2020 to 12.16 in 2021. Also, overall TB incidence in the US increased by 9.4% in 2021, following a significant decrease in 2020. Masks, respirators, nebulizers, polysomnography devices, and BiPAP devices are highly used during and post TB treatment. Thus, the increasing cases of TB propel the usage of respiratory care devices and drive the market growth. In recent years, COVID-19 has taken a significant place in the list of infectious respiratory diseases. The rising number of COVID-19 cases caused profound disruption and led to a high mortality rate. Additionally, the impact of the COVID-19 pandemic is historic and pushed the medical R&D sector to a new, rapidly moving pace. For instance, in May 2020McKinsey & Company surveyed COVID-19 implications for life sciences R&D. For the survey, 300 R&D functional leaders were convened as a respondent to explore the implications of the pandemic on the medical R&D sector.

The outcome survey revealed that R&D spent an average of 40-50% of their time on crisis management. The figure rises to 80% for contract manufacturing organizations (CMO) and other medical leaders. Due to the high usage of nebulizers in treating infectious respiratory diseases, the demand for nebulizers has rapidly grown in the last few years, eventually propelling the respiratory care devices market. Many pharmaceuticals focus on developing effective therapies, which can be administered via nebulizers. For instance, in May 2021Vectura and Inspira Pharmaceutical announced a collaboration to establish a potential COVID-19 therapy. Vectura will test IPX formulation to lungs through Vectura’s FOX vibrating mesh nebulizer. FOX vibrating mesh nebulizer has boosted the market in the preceding years.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the respiratory care devices market growth at a notable CAGR during the forecast period.

North America Respiratory Care Devices Market SegmentationThe North America respiratory care devices market is segmented on the basis of product, indication, end user, and country. Based on product, the market is segmented into therapeutic devices, monitoring devices, diagnostics devices, and consumables & accessories. The market for the therapeutics devices segment is sub segmented into positive airway pressure (PAP) devices, oxygen concentrator, ventilators, inhalers, nebulizers, humidifiers, and others. The market for the monitoring device segment is sub segmented into pulse oximeters, scenography, and gas analyzers. The market for the The diagnostic devices segment is further segmented into spirometers, polysomnography devices, peak flow meters, and other diagnostic devices. The market for the consumables & accessories segment is sub segmented into masks, disposable resuscitators, tracheostomy tubes, breathing circuits, and other consumables and accessories. By indication, the North America respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and others. Based on end user, the market is segmented into hospitals, home care, and ambulatory care. Based on country, the North America respiratory care devices market is segmented into the US, Mexicoand Canada.

Companies Mentioned Koninklijke Philips NV, ResMed Inc., Medtronic, Masimo, THERMO FISHER SCIENTIFIC INC, Dragerwerk AG & Co. KGaA, Invacare Corporation, Getinge AB., Nihon Kohden Corporation, Air Liquide, and Teleflex Incorporated are a few major companies operating in the North America respiratory care devices market.

Key Topics Covered:

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Segmentation
1.3.1 North America Respiratory Care Devices Market – By Product
1.3.2 North America Respiratory Care Devices Market – By Indication
1.3.3 North America Respiratory Care Devices Market – By End User
1.3.4 North America Respiratory Care Devices Market – By Country

2. North America Respiratory Care Devices Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Respiratory Care Devices Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.3 Expert Opinion

5. North America Respiratory Care Devices Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Respiratory Diseases
5.1.2 Rapidly Increasing Cases of Asthma and COPD
5.1.3 Rising Number of Products Launches and Approvals
5.1.4 Growing R&D Investment for North America Respiratory Care Devices Market
5.2 Market Restraints
5.2.1 Cutthroat Competition among Market Players
5.2.2 Unfavourable Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Growing Demand for Home Care Therapeutic Devices
5.3.2 Technological Advancement in North America Respiratory Care Devices Market
5.4 Future Trends
5.4.1 Growing Adoption of Mobile/Digital North America Respiratory Care Devices Market
5.4.2 Paradigm Shift Towards Value-Based Technology Solutions
5.5 Impact Analysis

6. North America Respiratory Care Devices Market- Analysis
6.1 North America Respiratory Care Devices Market Revenue Forecast and Analysis
6.1.1 North America: North America Respiratory Care Devices Market, 2019-2028 (US$ Million)

7. North America Respiratory Care Devices Market Revenue and Forecasts To 2028- by Product
7.1 Overview
7.2 North America Respiratory Care Devices Market Share, By Product 2022 & 2028 (%)
7.2.1 North America: North America Respiratory Care Devices Market, by Product, 2019-2028 (US$ ‘Million)
7.2.1.1 North America: North America Respiratory Care Devices Market, by Therapeutic Devices, 2019-2028 (US$ ‘Million)
7.2.1.1.1 North America: North America Respiratory Care Devices Market, by Positive Airway Pressure (PAP) Devices, 2019-2028 (US$ ‘Million)
7.2.1.1.2 North America: North America Respiratory Care Devices Market, by Oxygen concentrator, 2019-2028 (US$ ‘Million)
7.2.1.1.3 North America: North America Respiratory Care Devices Market, by Inhalers, 2019-2028 (US$ ‘Million)
7.2.1.2 North America: North America Respiratory Care Devices Market, by Monitoring Devices, 2019-2028 (US$ ‘Million)
7.2.1.3 North America: North America Respiratory Care Devices Market, by Diagnostic Devices, 2019-2028 (US$ ‘Million)
7.2.1.4 North America: North America Respiratory Care Devices Market, by Consumables and Accessories, 2019-2028 (US$ ‘Million)
7.3 Therapeutic Devices
7.3.1 Overview
7.3.2 Therapeutic Devices: North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)
7.3.3 Positive Airway Pressure (PAP) Devices
7.3.3.1 Overview
7.3.3.2 Positive Airway Pressure (PAP) Devices: North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)
7.3.3.3 Continuous Positive Airway Pressure (CPAP)
7.3.3.3.1 Overview
7.3.3.3.2 Continuous Positive Airway Pressure (CPAP): North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)
7.3.3.4 Automatic Positive Airway Pressure (APAP) Devices
7.3.3.4.1 Overview
7.3.3.4.2 Automatic Positive Airway Pressure (APAP) Devices: North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)
7.3.3.5 Bilevel Positive Airway Pressure (BiPAP) Devices
7.3.3.5.1 Overview
7.3.3.5.2 Bilevel Positive Airway Pressure (BiPAP) Devices: North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)
7.3.4 Oxygen Concentrators
7.3.4.1 Overview
7.3.4.2 Oxygen Concentrators: North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)
7.3.4.3 Fixed Oxygen Concentrators
7.3.4.3.1 Overview
7.3.4.3.2 Fixed Oxygen Concentrators: North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)
7.3.4.4 Portable Oxygen Concentrators
7.3.4.4.1 Overview
7.3.4.4.2 Portable Oxygen Concentrators: North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)
7.3.5 Ventilators
7.3.5.1 Overview
7.3.5.2 Ventilators: North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)
7.3.6 Inhalers
7.3.6.1 Overview
7.3.6.2 Inhalers: North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)
7.3.6.3 Metered Dose Inhalers (MDI)
7.3.6.3.1 Overview
7.3.6.3.2 Metered Dose Inhalers (MDI): North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)
7.3.6.4 Dry Powder Inhalers
7.3.6.4.1 Overview
7.3.6.4.2 Dry Powder Inhalers: North America Respiratory Care Devices Market Revenue and Forecast To 2028 (US$ Million)

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center